News SI-BONE, Inc.

Equities

SIBN

US8257041090

Market Closed - Nasdaq Other stock markets 01:30:00 27/04/2024 am IST			5-day change	1st Jan Change
14.57 ^USD	+2.10%		-5.51%	-30.59%

28/03	Piper Sandler Initiates SI-Bone With Overweight Rating, Price Target is $25	MT
12/03	Transcript : SI-BONE, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 08:30 AM

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024	16/04	AQ
Piper Sandler Initiates SI-Bone With Overweight Rating, Price Target is $25	28/03	MT
Transcript : SI-BONE, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 08:30 AM	12/03
SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024	05/03	AQ
Morgan Stanley Raises SI-Bone Price Target to $26 From $25, Maintains Overweight Rating	27/02	MT
Truist Securities Adjusts SI-Bone Price Target to $24 From $26, Maintains Buy Rating	27/02	MT
Si-Bone: Q4 Earnings Snapshot	27/02	AQ
Transcript : SI-BONE, Inc., Q4 2023 Earnings Call, Feb 26, 2024	27/02
Earnings Flash (SIBN) SI-BONE Posts Q4 Revenue $38.9M, vs. Street Est of $38.6M	27/02	MT
SI-BONE, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	27/02	CI
SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance	27/02	AQ
SI-BONE, Inc. Provides Earnings Guidance for the Year 2024	27/02	CI
Si-bone Insider Sold Shares Worth $808,591, According to a Recent SEC Filing	22/02	MT
SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024	06/02	AQ
SI-Bone Implant Receives Expanded FDA Approval	30/01	MT
SI-Bone Shares Up After Receiving FDA Approval for Expanded Device Use	30/01	DJ
SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application	30/01	AQ
SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application	30/01	CI
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023	08/01	AQ
SI-Bone, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2023	08/01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News SI-BONE, Inc.

Equities

SIBN

US8257041090

Summary

Filters